UNSPSC 85494413: Supplement superior vena cava with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement superior vena cava with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UV07Z

UNSPSC 85494413 Supplement superior vena cava with autologous tissue substitute, open approach is a Commodity code that shows a significant mismatch between its nominal scope — a specific surgical procedure performed on cardiovascular tissue — and the actual work state and local governments are buying under this code. Recent solicitations posted against this code concern occupational medical surveillance, disability pension medical evaluations, surgical benefit carve-out administration, pharmacy benefit management, temporary health professional staffing, and pediatric detention facility medical services. None of these activities involve the surgical repair of the superior vena cava; the code appears to have been applied incorrectly or as a generic health services catch-all by the issuing jurisdictions. State and local buyers using this code do not appear to be sourcing the specific procedure the code nominally describes.

The geographic spread of recent activity includes Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Florida (Collier County), Texas (Harris County), and Washington (Washington State Department of Transportation). The issuing bodies span city and county health benefit programs, county pension boards, a state transportation department's employee health program, a county juvenile probation department, and a regional health system. No repeat buyers appear in the recent opportunities block. Without concrete evidence that state and local governments are actually soliciting vena cava repair services under this code, the code does not represent a viable procurement category for firms pursuing health services or surgical supply contracts with public sector buyers. Business development professionals should verify whether opportunities posted to this code genuinely reflect surgical tissue transplant procurement or whether issuers are misclassifying broader health services activity.